Search

Your search keyword '"Roukens, A."' showing total 676 results

Search Constraints

Start Over You searched for: Author "Roukens, A." Remove constraint Author: "Roukens, A."
676 results on '"Roukens, A."'

Search Results

51. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy

57. Host biomarker-based quantitative rapid tests for detection and treatment monitoring of tuberculosis and COVID-19

58. A comparison of two Fendrix hepatitis B vaccination schedules in patients with inflammatory bowel disease

59. Bacillus Calmette-Guérin vaccine to reduce healthcare worker absenteeism in COVID-19 pandemic, a randomized controlled trial

62. External validation of the PAGE-B score for HCC risk prediction in people living with HIV/HBV coinfection

65. BCG Vaccination of Health Care Workers Does Not Reduce SARS-CoV-2 Infections nor Infection Severity or Duration: a Randomized Placebo-Controlled Trial

68. Global transcriptional analysis identifies a novel role for SOX4 in tumor-induced angiogenesis

70. Host biomarker-based quantitative rapid tests for detection and treatment monitoring of tuberculosis and COVID-19

71. COVID-19 vaccine dose sparing: strategies to improve vaccine equity and pandemic preparedness

72. Safety and clinical impact of FEES – results of the FEES-registry

73. Daily disease severity in patients with COVID-19 admitted to the hospital: The SCODA (severity of coronavirus disease assessment) score.

74. Safety and Immunogenicity of Intradermal Fractional Dose Administration of the mRNA-1273 Vaccine: A Proof-of-Concept Study

75. Immunogenicity of an Additional mRNA-1273 SARS-CoV-2 Vaccination in People With HIV With Hyporesponse After Primary Vaccination

76. Erratum: Correction: Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study (PLoS medicine (2022) 19 10 (e1003979))

77. Erratum:Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study (PLoS Med (2022) 19:10 (e1003979) DOI: 10.1371/journal.pmed.1003979)

78. BCG Vaccination of Health Care Workers Does Not Reduce SARS-CoV-2 Infections nor Infection Severity or Duration: a Randomized Placebo-Controlled Trial

80. Prolonged activation of nasal immune cell populations and development of tissue-resident SARS-CoV-2-specific CD8+ T cell responses following COVID-19

81. Fibrotic-like abnormalities notably prevalent one year after hospitalization with COVID-19

85. Immune determinants of viral clearance in hospitalised COVID-19 patients

86. Immunogenicity of an additional mRNA-1273 SARS-CoV-2 vaccination in people living with HIV with hyporesponse after primary vaccination

87. Lupus anticoagulant associates with thrombosis in patients with COVID-19 admitted to intensive care units

90. Immunogenicity of an additional mRNA-1273 SARS-CoV-2 vaccination in people living with HIV with hyporesponse after primary vaccination

91. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy: A multinational prospective cohort study

93. Management of drug interactions with direct‐acting antivirals in Dutch HIV/hepatitis C virus‐coinfected patients: adequate but not perfect

96. Myocardial function in COVID-19 patients after hospital discharge: a descriptive study comparing the first and second 'wave' patients

97. COVID-19 vaccine dose sparing: strategies to improve vaccine equity and pandemic preparedness

98. Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV: a nationwide prospective cohort study in the Netherlands

99. Development of a Novel Microfluidic Co-culture model to study Organoid Vascularization

100. A highly virulent variant of HIV-1 circulating in the Netherlands

Catalog

Books, media, physical & digital resources